W. Mullally
Director/Board Member at THIOGENESIS THERAPEUTICS, CORP.
Net worth: 448 875 $ as of 2024-05-30
Profile
Mr. W.
H.
Mullally is an Independent Director at Thiogenesis Therapeutics Corp.
and a President at Sectorspeak, Inc. He is on the Board of Directors at Thiogenesis Therapeutics Corp.
and Thiogenesis Therapeutics, Inc. /New/.
Mr. Mullally was previously employed as a Director-Investor Relations by Functional Technologies Corp., a Director-Investor Relations by Medicure, Inc., a Head-Pharmaceutical Sales & Marketing by iNova Pharmaceuticals (Australia) Pty Ltd.
/Old/, and a Head-Pharmaceutical Sales & Marketing by Fournier Pharma SA. He also served on the board at Rozdil Capital Corp.
He received his MBA from Asper School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-08-10 | 875,000 ( 2.10% ) | 448 875 $ | 2024-05-30 |
W. Mullally active positions
| Companies | Position | Start |
|---|---|---|
| THIOGENESIS THERAPEUTICS, CORP. | Director/Board Member | 2018-05-02 |
| Sectorspeak, Inc. | Founder | 2008-02-29 |
Former positions of W. Mullally
| Companies | Position | End |
|---|---|---|
| ROZDIL CAPITAL CORPORATION | Director/Board Member | 2022-04-17 |
| MEDICURE INC. | Public Communications Contact | 2007-12-31 |
Bausch & Lomb (Australia) Pty Ltd.
 Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Sales & Marketing | 2004-12-31 |
Fournier Pharma SA
 Fournier Pharma SA Pharmaceuticals: MajorHealth Technology Fournier Pharma SA manufactures pharmaceutical products. The firm is also in the engaged in the research, development, production and marketing of molecules. The company has operations in Canada, China, Algeria, Bulgaria, Thailand and Turkey. It was founded in 1880 and is headquartered in Chenôve, France. | Sales & Marketing | 2000-12-31 |
| FUNCTIONAL TECHNOLOGIES CORP | Investor Relations Contact | - |
Training of W. Mullally
| Asper School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| THIOGENESIS THERAPEUTICS, CORP. | Finance |
| MEDICURE INC. | Health Technology |
| Private companies | 5 |
|---|---|
Rozdil Capital Corp.
 Rozdil Capital Corp. Financial ConglomeratesFinance Rozdil Capital Corp. operates as a capital pool company. It is engaged in the identification and evaluation of assets or businesses with a view to completing a Qualifying Transaction. The company was founded on May 3, 2018 and is headquartered in Toronto, Canada. | Finance |
| Sectorspeak, Inc. | |
Functional Technologies Corp.
 Functional Technologies Corp. Food: Major DiversifiedConsumer Non-Durables Functional Technologies Corp. develops and commercializes proprietary, yeast-based solutions in the food, beverage and healthcare industries. Its technologies include yeasts that prevent and reduce the formation of foul-smelling hydrogen sulphide and carcinogen and acrylamide, both by-products of food and beverage processing. The company was founded by Howard J. Louie and Geoffrey Conrad Lee on October 18, 1999 and is headquartered in Vancouver, Canada. | Consumer Non-Durables |
Bausch & Lomb (Australia) Pty Ltd.
Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Health Technology |
Fournier Pharma SA
Fournier Pharma SA Pharmaceuticals: MajorHealth Technology Fournier Pharma SA manufactures pharmaceutical products. The firm is also in the engaged in the research, development, production and marketing of molecules. The company has operations in Canada, China, Algeria, Bulgaria, Thailand and Turkey. It was founded in 1880 and is headquartered in Chenôve, France. | Health Technology |
- Stock Market
- Insiders
- W. Mullally
